GHRS Similar Chart Price Prediction
The price of GHRS is predicted to go up 198.96%, based on the high correlation periods with CSCI. The similarity of these two price pattern on the periods is 97.31%.
GHRS
CSCI
Up: 198.96%Similarity: 97.31%
GHRS Revenue Forecast
GHRS EPS Forecast
GHRS FAQs
What is GHRS eps forecast for next quarter？
GHRS Analyst's Forecast
Sumant Kulkarni
Canaccord Genuity
Strong Buy
2024-11-18
Price Target
$31 → $28
Upside
+195.67%
Canaccord lowered the firm's price target on GH Research to $28 from $31 and keeps a Buy rating on the shares. The firm said they reported its 3Q24 results recently and the key update was that the company completed enrollment for its European Phase 2b trial for GH001 (5-MeO-DMT or mebufotenin) for treatment-resistant depression (TRD), and continues to expect top-line data in 4Q24 or 1Q25.
